Trademark: 87601267
Word
MACRILEN (MACIMORELIN) GRANULES FOR ORAL SOLUTION
Status Date
Monday, October 22, 2018
Filing Date
Friday, September 8, 2017
Published for Opposition
Tuesday, January 23, 2018
Abandoned Date
Monday, October 22, 2018
5 Diagnostic preparations for medical use, namely, diagnostic preparations for identifying and detecting growth hormone deficiency
42 Medical and scientific research in the field of medicine and medical diagnostics
44 Medical and veterinary services, namely, medical testing for the diagnosis of growth hormone deficiency
Color is not claimed as a feature of the mark.
"(MACIMORELIN) GRANULES FOR ORAL SOLUTION"
Oct 22, 2018
Abandonment Notice Mailed - No Use Statement Filed
Oct 22, 2018
Abandonment - No Use Statement Filed
Apr 25, 2018
Assigned To Examiner
Mar 20, 2018
Noa E-Mailed - Sou Required From Applicant
Jan 23, 2018
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2018
Published For Opposition
Jan 3, 2018
Notification Of Notice Of Publication E-Mailed
Dec 13, 2017
Approved For Pub - Principal Register
Dec 13, 2017
Examiner's Amendment Entered
Dec 13, 2017
Notification Of Examiners Amendment E-Mailed
Dec 13, 2017
Examiners Amendment E-Mailed
Dec 13, 2017
Examiners Amendment -Written
Dec 13, 2017
Assigned To Examiner
Sep 20, 2017
Applicant Amendment Prior To Examination - Entered
Sep 19, 2017
Assigned To Lie
Sep 15, 2017
Notice Of Design Search Code E-Mailed
Sep 14, 2017
New Application Office Supplied Data Entered In Tram
Sep 12, 2017
Teas Voluntary Amendment Received
Sep 12, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
